Dr. Ilya Tsimafeyeu is an internationally renowned expert and leading specialist in the treatment of kidney cancer. With extensive experience and a distinguished career, Dr. Tsimafeyeu has made significant contributions to the field of oncology.
Over the years, Dr. Tsimafeyeu has been an integral part of numerous well known organizations. He has served on the expert councils and organizing committees of the Kidney Cancer Association (USA), Kidney Cancer Research Bureau (Russia), Kidney Cancer Patient League (Russia-Belarus-Ukraine), VHL Alliance (USA), and the International Kidney Cancer Coalition (IKCC). His leadership roles include serving as the director of the Institute of Oncology at Hadassah Medical Moscow and co-founding the Russian Society of Clinical Oncology, where he was the first director.
Dr. Tsimafeyeu is also a dedicated educator and active participant in the global oncology community. He is a faculty member of the College of the European School of Oncology (ESCO, Italy) and serves on the Central and Eastern Europe Regional Council of the American Society of Clinical Oncology (ASCO, USA). Additionally, he contributes his expertise as an editorial board member for the Kidney Cancer Journal (USA) and OncoDaily, an international cancer news platform.
His exceptional work in oncology has earned him prestigious awards, including the ASCO Merit Award, ASCO IDEA Award, and the Prix Galien Award. Dr. Tsimafeyeu is deeply involved in drug development and clinical trials, continually advancing the field and improving patient outcomes.
With a commitment to excellence and a passion for innovation, Dr. Ilya Tsimafeyeu remains at the forefront of kidney cancer treatment and research, dedicated to improving the lives of patients worldwide.
Languages: English, Russian
Learn more |